Century Therapeutics to Attend 2026 Jefferies Global Healthcare Conference in London
Globe Newswire•14/10/2026•08:05 ET
0
Key Highlights
- ➤Century Therapeutics (IPSC) will attend the 2026 Jefferies Global Healthcare Conference November 18, 2026.
- ➤Century Therapeutics is developing iPSC-derived cell therapies for type 1 diabetes and autoimmune diseases.
- ➤Century Therapeutics is advancing an iPSC-derived cell therapy pipeline for autoimmune diseases and cancer.
Expert Statements
Douglas Carr, Senior Vice President, Finance at Century Therapeutics
“Douglas Carr”
PHILADELPHIA, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies for type 1 diabetes (T1D) and other autoimmune diseases, today announced that the company will attend the upcoming 2026 Jefferies Global Healthcare Conference in London on November 18, 2026.
If you are interested in a 1x1 meeting with the Century Therapeutics team during the conference, please reach out to your respective Jefferies representative.
Get started
Create a free account to read the full story.